Beta-blockers show no benefit for heart attack patients with normal heart function

The REDUCE-AMI trial found that long-term beta-blocker therapy does not reduce mortality risk in acute myocardial infarction patients with preserved left ventricular ejection fraction compared to no beta-blocker treatment.

Related Keywords

New Zealand ,Estonia ,Canada ,Sweden ,Canadian ,Swedish , ,Canadian Cardiovascular Society ,New England Journal ,Randomized Evaluation ,Decreased Usage ,Acute Myocardial Infarction ,Myocardial Infarction ,Preserved Ejection ,Image Credit ,Swedish Web System ,Evidence Based Care ,Heart Disease Evaluated According ,Recommended Therapies ,Heart ,Heart Attack ,Angiography ,Asthma ,Bradycardia ,Cardiovascular Disease ,Efficacy ,Heart Disease ,Heart Failure ,Hospital ,Hypotension ,Medicine ,Ortality ,Pacemaker ,Research ,Stroke ,